Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | BLNK |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → BLNK |
| (<<) CASP10 → BLNK |
| (<<) CASP4 → BLNK |
| (<<) CBFA2T3 → BLNK |
| (<<) CCND2 → BLNK |
| (<<) CD79A → BLNK |
| (<<) GBP2 → BLNK |
| (<<) HLA-DOA → BLNK |
| (<<) IRF1 → BLNK |
| (<<) LTB → BLNK |
| (<<) PIK3CG → BLNK |
| (<<) PRKCH → BLNK |
| (<<) PTGER4 → BLNK |
| (<<) RAP1A → BLNK |
| (<<) RASSF5 → BLNK |
| (<<) RCAN1 → BLNK |
| (<<) SOCS1 → BLNK |
| (<<) VAV1 → BLNK |
| (<<) VIM → BLNK |
| Downstream (Children) |
|---|
| BLNK → ASB2 (>>) |
| BLNK → BMP2 (>>) |
| BLNK → EPHB3 (>>) |
| BLNK → FOXC2 (>>) |
| BLNK → FZD6 (>>) |
| BLNK → FZD9 (>>) |
| BLNK → IL18 (>>) |
| BLNK → LEMD1 (>>) |
| BLNK → LTA4H (>>) |
| BLNK → MAP3K1 (>>) |
| BLNK → MREG (>>) |
| BLNK → NFIA (>>) |
| BLNK → PLA2G4A (>>) |
| BLNK → PLA2G4C (>>) |
| BLNK → PTGS2 (>>) |
| BLNK → SCARB1 (>>) |
| BLNK → SERPINB1 (>>) |
| BLNK → SERPINB5 (>>) |
| BLNK → SLC16A6 (>>) |
| BLNK → SOX8 (>>) |
| BLNK → TMEM154 (>>) |
| BLNK → TRERF1 (>>) |
| BLNK → UBE2J1 (>>) |
